Li Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Thoracic cancer

Therapeutic advances in medical oncology

Cancer innovation

Peking Union Medical College Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peking Union Medical College Hospital

China

Professor :: Pulmonary and Critical Care Medicine

Publications

Yang Du, Xiao-Yan Liu, Li Zhang
Combining immune-checkpoint inhibitors with tocilizumab to treat a lung adenocarcinoma patient with pre-existing polymyalgia rheumatica: A case report. Thoracic cancer (2023)
Kang Miao, Xiao-Tong Zhang, Hanping Wang, Xiao-Yan Si, Li Zhang
Savolitinib versus crizotinib for treating MET positive non-small cell lung cancer. Thoracic cancer (2023)
Li Zhang, Yongsheng Wang, Lizhu Lin, Yongfeng Yu, Shun Lu
Chinese multidisciplinary expert consensus on the management of adverse drug reactions associated with savolitinib. Therapeutic advances in medical oncology 15 (2023)
Xiao-Yan Si, Xueqing Zheng, Xinlun Tian, Hanping Wang, Yan Xu, Jing Zhao, Min-Jiang Chen, Wei Zhong, Mengzhao Wang, Li Zhang, Xiao-Tong Zhang
Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case-control study. Thoracic cancer (2023)
Kang Miao, Li Zhang, Xiaoyan Si
Pyrotinib-associated acute kidney injury: A case report. Cancer innovation 1 (4) (2022)
Kang Miao, Shuangni Yu, Jun Ni, Xiao-Tong Zhang, Li Zhang
Second primary tumor after immune checkpoint inhibitor therapy: A case report. Thoracic cancer 13 (7) (2022)
Jun Ni, Xiao-Yan Si, Li Zhang
Non-small-cell lung cancer with ERBB2 mutation in non-tyrosine kinase domain benefits from pyrotinib: A case report. Thoracic cancer 12 (8) (2021)
Jun Ni, Xiao-Tong Zhang, Hanping Wang, Xiao-Yan Si, Yan Xu, Jing Zhao, Min-Jiang Chen, Li Zhang, Mengzhao Wang
Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period. Thoracic cancer 13 (4) (2021)
Xiao-Yan Si, Jinwan Wang, Ying Cheng, Jianhua Shi, Liying Cui, Helong Zhang, Yunchao Huang, Wei Liu, Lei Chen, Jiang Zhu, Shucai Zhang, Wei Li, Yan Sun, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Lin Yang, Li Zhang
A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer. Therapeutic advances in medical oncology 12 (2020)

Li Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Li Zhang